SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 746.92 millions for the September 2024 quarter. The mentioned figure indicates a growth of about 29.16% as compared to Rs. 578.29 millions during the year-ago period.Profit after tax for the quarter ended September 2024 reported a huge growth of 53.36% to Rs. 114.59  millions from Rs. 74.72 millions.OP of the company witnessed a marginal growth to 179.39 millions from 106.39 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 746.92 578.29 29.16 1361.31 1179.82 15.38 2087.02 2367.14 -11.83
Other Income 16.54 22.74 -27.26 30.98 42.71 -27.46 92.79 57.34 61.82
PBIDT 179.39 106.39 68.62 296.21 212.73 39.24 323.46 398.85 -18.90
Interest 2.29 2.21 3.62 4.44 3.71 19.68 8.14 4.13 97.09
PBDT 177.10 104.18 69.99 258.92 209.02 23.87 315.32 360.13 -12.44
Depreciation 23.41 4.55 414.51 34.13 8.48 302.48 16.63 12.05 38.01
PBT 153.69 99.63 54.26 224.79 200.54 12.09 298.69 348.08 -14.19
TAX 39.10 24.91 56.97 56.91 51.03 11.52 74.06 80.87 -8.42
Deferred Tax 12.26 -0.92 -1432.61 14.20 -0.81 -1853.09 -1.54 4.55 -133.85
PAT 114.59 74.72 53.36 167.88 149.51 12.29 224.63 267.21 -15.94
Equity 132.42 130.99 1.09 132.42 130.99 1.09 132.19 130.99 0.92
PBIDTM(%) 24.02 18.40 30.55 21.76 18.03 20.68 15.50 16.85 -8.02

Jagsonpal Pharma Share Price

192.80 -0.85 (-0.44%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×